logo

For the Inventor, By the Inventor

Emeryville, CA, United States of America

4D Molecular Therapeutics Inc.


USPTO Granted Patents = 15


Trademarks = 1

Forward Citations = 27

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Melissa Kotterman (15 out of 18 patents)

silverMedal David H Kirn (13 out of 16 patents)

bronzeMedal David Schaffer (11 out of 14 patents)

4.  Peter Francis (7 out of 8 patents)

5.  Paul Szymanski (2 out of 3 patents)

6.  Melissa Calton (2 out of 2 patents)

7.  Johnny Gonzales (2 out of 2 patents)

8.  Roxanne Croze (2 out of 2 patents)

9.  Christopher Schmitt (2 out of 2 patents)

10.  Kevin Whittlesey (1 out of 2 patents)

11.  Meredith Leong (2 patents)

12.  Christian Burns (0 patent)


15 patents:

1. 11840704 - Adeno-associated virus variant capsids and methods of use thereof (2023-12-12),
2. 11807868 - Adeno-associated variants, formulations and methods for pulmonary delivery (2023-11-07),
3. 11766489 - Adeno-associated virus variant capsids and use for inhibiting angiogenesis (2023-09-26),
4. 11766487 - Treatments for retinal disease (2023-09-26),
5. 11576983 - Treatments for retinal disease (2023-02-14),
6. 11524081 - Codon optimized REP1 genes and uses thereof (2022-12-13),
7. 11499166 - Adeno-associated variants, formulations and methods for pulmonary delivery (2022-11-15),
8. 11419949 - Adeno-associated virus variant capsids and methods of use thereof (2022-08-23),
9. 11364308 - Adeno-associated virus variant capsids and methods of use thereof (2022-06-21),
10. 11357870 - Codon optimized REP1 genes and uses thereof (2022-06-14),
11. 11345930 - Codon optimized RPGRORF15 genes and uses thereof (2022-05-31),
12. 11198858 - Codon optimized GLA genes and uses thereof (2021-12-14),
13. 11179477 - Method of using adeno-associated virus with variant capsid (2021-11-23),
14. 11167041 - Adeno-associated virus variant capsids and methods of use thereof (2021-11-09),
15. 11118192 - Adeno-associated virus variant capsids and methods of use thereof (2021-09-14),
Company Overview
4D Molecular Therapeutics Inc. is a biotechnology company based in Emeryville, California, specializing in the development of gene therapies. The company focuses on harnessing its proprietary 4D technology platform to create targeted and efficient gene delivery systems. By leveraging advanced molecular engineering, 4D Molecular Therapeutics aims to address a range of genetic disorders and diseases, enhancing therapeutic outcomes through precision medicine. Their innovative approach positions them at the forefront of the evolving landscape of gene therapy solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4D Molecular Therapeutics Inc. USPTO Patent Assignee Logo
15 Patents

#38 in Emeryville, CA

#5,031 in California

#21,068 in US

#39,959 in the World

Emeryville, CA (US)
Emeryville, CA, United States of America

4D Molecular Therapeutics Inc.

Forward Citations = 27

12 inventors:

goldMedal Melissa Kotterman (15 out of 18 patents)

silverMedal David H Kirn (13 out of 16 patents)

bronzeMedal David Schaffer (11 out of 14 patents)

4.  Peter Francis (7 out of 8 patents)

5.  Paul Szymanski (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: 4D Molecular Therapeutics Inc.. Retrieved from https://idiyas.com/company/4d-molecular-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…